首页 > 专栏 > The Lancet HIV The Lancet HIV 共 22 条资讯 [Profile] 25 years of the Alliance for Public Health in Ukraine 2026-06-28 11:45:31 [Articles] Fixed-dose daily doravirine (100 mg) with islatravir (0·25 mg) versus bictegravir, emtricitabine, and tenofovir alafenamide for initial HIV-1 therapy: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trial 2026-06-28 11:45:31 [Review] The vaginal microbiome and HIV acquisition risk 2026-06-28 11:45:31 [Comment] The caveats of short-cycle antiretroviral therapy in adolescents living with HIV 2026-06-28 11:45:31 [Articles] Efficacy and safety of short-cycle, dolutegravir-based antiretroviral therapy in adolescents living with HIV (BREATHER Plus): a multicentre, open-label, randomised, parallel, two-arm, non-inferiority trial 2026-06-28 11:45:31 [Viewpoint] Targeted universalism for long-acting PrEP: an urgent need to avoid risk targeting and build population-level impact 2026-06-28 11:45:31 [Comment] Ending HIV requires research in and with South Africa 2026-06-28 11:45:31 [Feature] Russia's internet blackout affects HIV services 2026-06-28 11:45:31 [Feature] Lenacapavir PrEP roll-out begins in Africa 2026-06-28 11:45:31 [Articles] Trends in incidence of HIV and other sexually transmissible infections among transgender people in Australia: a retrospective 10-year national clinical cohort study 2026-06-28 11:45:31 [Articles] Safety and efficacy of switching to bictegravir–lenacapavir versus continuing bictegravir–emtricitabine–tenofovir alafenamide in virologically suppressed people with HIV-1 (ARTISTRY-2): a double-blind, multicentre, randomised, controlled, phase 2026-06-28 11:45:31 [Articles] Global mental health disparities among transgender women and transfeminine people living with HIV: a systematic review and meta-analysis of 63 studies 2026-06-28 11:45:31 [Comment] Drug policy changes threaten HIV and HCV control in Georgia 2026-06-28 11:45:31 [Articles] Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, VRC07-523LS, and PGT121.414.LS infused intravenously or subcutaneously (HVTN 140/HPTN 101 part B): a phase 1, randomised trial 2026-06-28 11:45:31 [Feature] Uganda integrates HIV care into general medical services 2026-06-28 11:45:31 [Culture] The Soviet response to the AIDS crisis 2026-06-28 11:45:31 [Comment] Are screening periods in ART-naive trials justified in the era of rapid ART? 2026-06-28 11:45:31 [Culture] A story of faith, stigma, and survival in Bangui 2026-06-28 11:45:31 [Articles] Short-cycle 4-days-per-week maintenance two-drug therapy in people living with HIV (ANRS-177 DUETTO): a randomised, open-label, multicentre, non-inferiority trial 2026-06-28 11:45:31 [Articles] Trends in AIDS-defining illnesses among people living with HIV in clinical care in Europe: results from the EuroSIDA multicentre cohort study (2003–24) 2026-06-28 11:45:31 12下一页 » 相关分类 The Lancet HIV The Lancet #!/slash/note #UNTAG (B)(F)uzzing on my world (Hi)story (IN)SECURE Magazine Notification (gdb) break *0x972 - 带鱼博客 BeltfishBlog - ./kwaa.dev .NET Blog .Trash /home/rook1e 00's Adventure 0kami's Blog 0x41414141 in ?? () 0x7f Blog 0xRick Owned Root ! 0xd00's blog 1 Byte 1A23 Blog 1A23 Studio 1Link.Fun 1stwebdesigner 251 2BAB 的工程博客 2ch中文网 360 CERT 360 Netlab Blog - Network Securi 38号车评中心